NCT01129856View on ClinicalTrials.gov

Safety and Efficacy Study of EGP-437 (Dexamethasone Phosphate Formulated for Ocular Iontophoresis) to Treat Dry Eye

PHASE3CompletedINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

April 30, 2011

Conditions
Dry Eye
Interventions
DRUG

Dexamethasone phosphate ophthalmic solution

Transscleral iontophoresis delivery of EGP-437 (dexamethasone phosphate formulated for ocular iontophoresis)

DRUG

Sodium citrate buffer solution

Sodium citrate buffer solution 100 mM

Trial Locations (5)

23502

Virginia Eye Consultants, Norfolk

38119

Total Eye Care, Memphis

06708

The Eye Care Group, Waterbury

04240

Central Maine Eye Care, Lewiston

01810

Andover Eye Associates, Andover

Sponsors
All Listed Sponsors
lead

Eyegate Pharmaceuticals, Inc.

INDUSTRY